Process analytical technologies in the pharmaceutical industry: the FDA's PAT initiative

被引:138
|
作者
Hinz, DC [1 ]
机构
[1] Schering AG, Proc Control Dept, Global CMC Dev, D-13342 Berlin, Germany
关键词
Drug products plants;
D O I
10.1007/s00216-005-3394-y
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The initiative taken by the FDA on the use of process analytical technologies (PAT) in the pharmaceutical industry is discussed. Analytical tools have evolved to such an extent that they are capable of dealing with the complex matrix of multiple dosage forms and of providing data in meaningful way. In the process, near-infrared spectroscopy (NIR), radio frequency, and microwaves have been applied for moisture determination. The first PAT team will, continue its training, and a second PAT team will be selected to begin training for CMC review and cGMP inspections of applications that utilize PAT.
引用
收藏
页码:1036 / 1042
页数:7
相关论文
共 50 条
  • [21] Workshop 1: New Directions in Pharmaceutical Process Development and Manufacturing: Process Analytical Technology (PAT), Quality by Design (QbD), Design Space (DS), and other FDA Initiatives
    Ozturk, Sadettin S.
    Jenkins, Nigel
    PROCEEDINGS OF THE 21ST ANNUAL MEETING OF THE EUROPEAN SOCIETY FOR ANIMAL CELL TECHNOLOGY (ESACT), 2009, 2012, 5 : 731 - 733
  • [22] On the Use of Temperature Measurements as a Process Analytical Technology (PAT) for the Monitoring of a Pharmaceutical Freeze-Drying Process
    Vallan, Alberto
    Fissore, Davide
    Pisano, Roberto
    Barresi, Antonello A.
    PHARMACEUTICS, 2023, 15 (03)
  • [23] Raman Spectroscopy for Process Analytical Technologies of Pharmaceutical Secondary Manufacturing
    Brigitta Nagy
    Attila Farkas
    Enikő Borbás
    Panna Vass
    Zsombor Kristóf Nagy
    György Marosi
    AAPS PharmSciTech, 20
  • [24] Raman Spectroscopy for Process Analytical Technologies of Pharmaceutical Secondary Manufacturing
    Nagy, Brigitta
    Farkas, Attila
    Borbas, Eniko
    Vass, Panna
    Nagy, Zsombor Kristof
    Marosi, Gyorgy
    AAPS PHARMSCITECH, 2019, 20 (01)
  • [25] Multivariate analysis in the pharmaceutical industry: enabling process understanding and improvement in the PAT and QbD era
    Ferreira, Ana P.
    Tobyn, Mike
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2015, 20 (05) : 513 - 527
  • [26] The current status of process analytical technologies in the dairy industry
    Munir, M. Tajammal
    Yu, W.
    Young, B. R.
    Wilson, David I.
    TRENDS IN FOOD SCIENCE & TECHNOLOGY, 2015, 43 (02) : 205 - 218
  • [27] The pharmaceutical industry, academic medicine, and the FDA
    Anders, Thomas F.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (05) : 727 - 730
  • [28] The pharmaceutical industry, academic medicine and the FDA
    Zito, Julie Magno
    Koplewicz, Harold S.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (03) : 275 - 277
  • [29] FDA bringing services to pharmaceutical Industry
    不详
    R&D MAGAZINE, 2003, 45 (09): : 72 - 72
  • [30] Process analytical technology (PAT): applications to flow processes for active pharmaceutical ingredient (API) development
    Talicska, Courtney N.
    O'Connell, Eamon C.
    Ward, Howard W.
    Diaz, Angel R.
    Hardink, Mark A.
    Foley, David A.
    Connolly, Douglas
    Girard, Kevin P.
    Ljubicic, Tomislav
    REACTION CHEMISTRY & ENGINEERING, 2022, 7 (06) : 1419 - 1428